Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe

Teva Pharmaceutical Industries Ltd.

announced today that Dr. Rob Koremans, has been appointed President and CEO, Teva Europe and will join the company in March 2012. Dr. Koremans joins Teva after serving as CEO for Zentiva and most recently Senior Vice President Generic Strategy and Development at Sanofi-Aventis. After six intensive years, Dr. Gerard van Odijk, Teva Europe's current President and CEO has decided to step down.